The MCE webinar is committed to offering an official platform for global experts and researchers in the fields of medicine, pharmacy, biology, and chemistry. It provides a free opportunity for professionals to engage in communication and showcase their latest research advancements in prominent areas such as signaling pathways, drug development, oncology, neuroscience, metabolism, immunology, and other relevant fields. By facilitating knowledge exchange, the MCE webinar aims to contribute to the global biopharmaceutical industry by promoting extensive sharing of information and expertise.

New Oncology Targets from Fragment Leads

John Spencer, PhD

• Head of Medicinal Chemistry, Sussex Drug Discovery Center

• Scientific Advisory Member (grant committee) Prostate Cancer UK

Learn More
Date:
  • September 19, 2024 (Thursday)
Time:
  • 10:00 EDT
  • 15:00 BST
  • 16:00 CEST

TGF-β Signaling and Organ Fibrosis

Joice Thomas Gavali, PhD

• In Pharmacology at the Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN) en México.

• Postdoctoral Research Associate at Thomas Jefferson University.

• American Heart Association Member.

• President- Thomas Jefferson University's Jefferson Postdoctoral Association.

Learn More
Date:
  • August 28, 2024 (Wednesday)
Time:
  • 13:00 - 14:00 ET
  • 12:00 - 13:00 CT
  • 10:00 - 11:00 PT
  • 19:00 - 20:00 CEST

Tissue-Specific Differences in The Induction of Type 2 Immunity are Controlled by Specialized Dendritic Cell Subsets

Johannes U Mayer, PhD

• Professor for Dermatological Immunotherapy, University Medical Center of the Johannes

  Gutenberg-University Mainz

• Member of the Research Center for Immunotherapy, the Center for Healthy Ageing and the Institute

  for Quantitative & Computational Bioscievvnces

Learn More
Date:
  • June 18, 2024 (Tuesday)
Time:
  • 10:00 CEST
  • 13:30 IST
  • 17:00 JST & KST

Cellular Senescence in Cornelia de Lange Syndrome :
A Pharmacological Target?

Dr. Michel Pucéat

• Research director at Inserm

• Team leader and senior researcher

Learn More
Date:
  • April 30, 2024 (Tuesday)
Time:
  • CEST 10:00
  • IST 13:30
  • JST & KST 17:00

Cancer Immunosuppression and How to Conquer it

Xin Lu Ph.D.

• John M. and Mary Jo Boler Collegiate Associate Professor, University of Notre Dame

• Full Member of Tumor Microenvironment and Metastasis Program, Indiana University

  Simon Comprehensive Cancer Center

Learn More
Date:
  • March 13, 2024 (Wednesday)
Time:
  • 10:00 EDT
  • 14:00 GMT
  • 15:00 CET

30 Years in PI 3-kinase Research: Lessons Learned
and Looking to the Future

Bart Vanhaesebroeck Ph.D.

• Professor of Cell Signalling at the UCL Cancer Institute
• Elected member of EMBO and the UK Academy of Medical Sciences

Learn More
Date:
  • November 15, 2023 (Wednesday)
Time:
  • 09:00 CST
  • 15:00 GMT
  • 16:00 CET

Stressing Out Therapy Resistant Cancers

Xi Chen Ph.D.

• Baylor College of Medicine Associate Professor
• Cullen Duncan McAshan Endowed Chair in Cancer Research

Learn More
Date:
  • November 21, 2023 (Tuesday)
Time:
  • 09:00 CST
  • 15:00 GMT
  • 16:00 CET